期刊文献+

格列吡嗪壳聚糖-三聚磷酸钠pH敏感性微球的制备及性能研究 被引量:1

Preparation and properties evaluation for glipizide loaded CS-TPP pH sensitive microspheres
原文传递
导出
摘要 目的:以壳聚糖为载体,制备格列吡嗪壳聚糖-三聚磷酸钠pH敏感性微球,并对其性能进行研究。方法:采用正交试验设计法L9(34)优化处方组成及微球制备工艺,通过扫描电镜法、红外光谱法对微球的表面形态及内部结构进行表征,并对其体外释放性能进行研究。结果:最佳工艺条件下制得的微球形状圆整、表面光滑,平均包封率、载药量、粒径分别为75.17%,11.04%和50μm。此微球在模拟胃液中3 h,累积释放率达50%,转移到肠液中19 h后,累积释放率达80%。结论:该微球具有明显的pH敏感性和控释性能。 ORIECTIVE To prepare the pH sensitive glipizide loaded CS-TPP microspheres, and to investigate its properties of the microspheres. METHODS Chitosan was selected as carrier material. Glipizide loaded CS-TPP microspheres composition and preparation technology was optimized by orthogonality of L9(3^4 ). The surface morphology and structure of the microsphere was characterized by scanning electron microscopy (SEM) and FTIR, respectively. Also, the microsphere release in vitro was determined. RESULTS Glipizide loaded microspheres under the optimum preparation conditions showed a round shape and smooth surface, and average encapsulation efficiency, loading efficiency and particle diameter were 75.17 %, 11.04 % and 50 μm, respectively. In addition, the sequential release amount of glipizide from the hydrogel microspheres in SGF was 50 % for 3 h, and then moved to SIF, this value approached 80% for 24 h. CONCLUSION The method of the preparation was successful, and the microspheres occupied obviously pH sensitivety and controlled release effect in vitro.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2012年第4期274-279,共6页 Chinese Journal of Hospital Pharmacy
基金 兰州大学交叉学科青年创新研究基金(编号:LZUJC200929)
关键词 格列吡嗪 壳聚糖 PH敏感性 微球 控释性能 glipizide chitosan pH sensitivety microspheres controlled release property
  • 相关文献

参考文献11

  • 1Pillai CKS, Paul W, Sharma CP. Chitin and chitosan polymers: Chemistry,solubility and fiber formation[J]. Progress in Poly- mer Science,2009,43(7) : 641-678.
  • 2Rajan K Verma, Garg SJ. Development and evaluation of os motically controlled oral drug delivery system of glipizide[J]. European Journal of Pharmaceutics and Biopharmaeeutics, 2004,57(3) : 513-525.
  • 3Jain A, Ghosh B, Rajgor N, et al. Passive and iontophoretie permeation of glipizide[J]. European Journal of Pharmaceutics and Biopharmaceutics,20118,69(3) : 958-963.
  • 4艾国,程远国.长效微球注射剂及其在糖尿病治疗领域中的应用[J].中国药剂学杂志(网络版),2008(4):206-213. 被引量:5
  • 5Dai YN, Li P, Zhang JP, et al. Swelling characteristics and drug delivery properties of nifedipine loaded pH sensitive alginate- chitosan hydrogel beads[J]. Journal of Biomedical Materials Research (Applied Biomaterials ), 21108,86B(2) : 493-500.
  • 6Luo YC, Zhang B, Cheng WH, et al. Preparation, characteriza- tion and evaluation of selenite-loaded ehitosan/TPP nanoparti- des with or without zein eoating[J]. Carbohydrate Polymers, 2010,82: 942-951.
  • 7李国明,叶俊生,郑国红,刘聪,汪朝阳.左旋多巴-壳聚糖微球的制备及其释药性能[J].应用化学,2007,24(9):1062-1065. 被引量:6
  • 8Sankalia MG, Mashru RC, Mashru J M, et al. Reversed chi- tosan-alginate polyelectrolyte complex for stability improve- ment of alpha-amylase: optimization and physicoehemical char- acterization[J]. European Journal Pharmaceutics Biopharma- ceutics,2007,65(2) : 215-232.
  • 9Chen SC,Wu YC, Mi FL,et al. A novel pH-sensitive hydrogel composed of N, O-carboxymethyl chitosan and alginate cross linked by genipin for protein drug delivery[J]. Journal Control Release,2004,96(3) : 285-300.
  • 10Verma RK,Garg S. Selection of excipients for extended release formulations of GL through drug excipient compatibility tes- ting[J]. Journal of Pharmaceutical and Biomedical Analysis, 2005,38(4) : 633-644.

二级参考文献13

  • 1洪晓丹,任斌,王振宁,黎曙霞,李卓敏,林婉贞,唐蕾.2000年~2003年广东省抗震颤麻痹药物应用分析[J].中国医院用药评价与分析,2005,5(4):220-222. 被引量:2
  • 2尹东锋,吴诚,鲁莹,杨凌,钟延强.胰高血糖素样肽-1长效注射微球的制备及其体外释放研究[J].药学服务与研究,2005,5(3):243-247. 被引量:4
  • 3Pan Y,Li Y J,Zhao H Y,Zheng J M,Xu H,Wei G,Hao J S,Cui F D.Int J Pharm[J],2002,249(1-2):139
  • 4Anal A K,Stevens W F,Remunan-Lopez C.Int J Pharm[J],2006,312(1-2):166
  • 5Shu X Z,Zhu K J.Int JPharm[J],2000,201(1):51
  • 6Mi F L,Sung H W,Shyu S S,Su C C,Peng C K.Polymer[J],2003,44(21):6521
  • 7Mi F L,Tan Y C,Liang H F,Sung H W.Biomaterials[J],2002,23(1):181
  • 8Puttipipatkhachorn S,Nunthanid J,Yamamoto K,Peck G E.J Control Release[J],2001,75(1-2):143
  • 9Shu X Z,Zhu K J.Eur J Pharm Biopharm[J],2002,54(2):235
  • 10Brime B,Ballesteros M P,Frutos P.J Microencapsulation[J],2000,17(6):777

共引文献9

同被引文献6

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部